Executive Intelligence

Dennis Kogan

Co-Founder

Co-founder of Caresyntax, the surgical intelligence platform deployed in more than 4,000 operating rooms worldwide.

In this profile

Quick Facts

  • Role Co-Founder
  • Company Caresyntax
  • Country United States
  • Industry AI in Healthcare
  • Founded 2013
  • Known For Caresyntax shows how operating-room data platforms combine vendor-neutral OR integration with real-world surgical evidence — its…
  • Status Active
  • Last Reviewed Jul 2026

Executive Summary

Dennis Kogan is co-founder of Caresyntax, a healthcare technology company building surgical intelligence platforms for operating rooms worldwide. Caresyntax's July 16, 2025 newsroom announcement states Kogan co-founded the company alongside Bjoern von Siemens to make surgery safer and smarter through data capture and AI analytics. Matt Krueger succeeded the founders as chief executive officer in that transition while Kogan and von Siemens remain involved in strategy and governance.Caresyntax describes its platform as deployed in more than 4,000 operating rooms, ingesting video, audio, device feeds, EMR data, and outcomes metrics.

Career Timeline

Verified company milestones linked to this executive’s organization.

  1. 2013 Company founded

    Caresyntax was founded in 2013 per the company profile source on file.

    Source
  2. 2013 Development

    2013: Caresyntax founded; Dennis Kogan and Bjoern von Siemens are co-founders.

    Source
  3. 2024 Funding

    August 15, 2024: Caresyntax raised $180 million through Series C extension and growth debt.

    Source
  4. 2025 Leadership

    July 16, 2025: Matt Krueger elevated to Chief Executive Officer, succeeding co-founders Kogan and von Siemens in operating leadership.

    Source

Connected Company

Connected Products

Connected Reports

Connected Insights

Industry Intelligence

Overview

Dennis Kogan is co-founder of Caresyntax, a healthcare technology company building surgical intelligence platforms for operating rooms worldwide. Caresyntax’s July 16, 2025 newsroom announcement states Kogan co-founded the company alongside Bjoern von Siemens to make surgery safer and smarter through data capture and AI analytics. Matt Krueger succeeded the founders as chief executive officer in that transition while Kogan and von Siemens remain involved in strategy and governance.

Caresyntax describes its platform as deployed in more than 4,000 operating rooms, ingesting video, audio, device feeds, EMR data, and outcomes metrics.

Role and company

Kogan co-founded Caresyntax in 2013 and served in operating leadership including chairman and CEO roles before Matt Krueger’s July 2025 elevation per Caresyntax newsroom. As co-founder, Kogan shaped Caresyntax’s vendor-neutral approach to OR data aggregation — a technical requirement when hospitals run multi-vendor surgical equipment stacks.

Caresyntax raised $180 million through a Series C extension and growth debt round announced August 15, 2024, reporting 50%+ organic revenue growth and 4,000+ OR deployments in its December 2024 highlights release.

Background and career context

Caresyntax newsroom identifies Kogan as company co-founder without a dedicated individual biography page on caresyntax.com reviewed July 2026. His public record is tied to Caresyntax’s founding narrative and CEO transition announcement rather than prior employer disclosures on the company domain.

Kogan’s co-founder partnership with Bjoern von Siemens combined complementary skills to build precision surgery analytics — a category competing with device-vendor-native OR data silos.

Company-building or leadership context

Under founding leadership, Caresyntax grew from 2013 founding to global OR deployments and $180M financing. The July 2025 CEO transition to Matt Krueger — described as succeeding company founders Dennis Kogan and Bjoern von Siemens — reflects a governance evolution common in growth-stage health-tech companies where professional operators scale sales while founders focus on strategy.

Caresyntax won the 2024 German AI Prize and joined the EU AI Pact per 2024 newsroom releases during Kogan’s co-founder tenure.

Public milestones

2013: Caresyntax founded by Dennis Kogan and Bjoern von Siemens. August 15, 2024: $180 million funding announced. July 16, 2025: Matt Krueger appointed CEO, succeeding founders Kogan and von Siemens. December 20, 2024: Company reported 50%+ organic revenue growth and 4,000+ OR deployments.

September 2024 German AI Prize and Fierce 15 2024 recognition appear in Caresyntax newsroom timeline.

Why their work matters

Caresyntax under Kogan’s co-founding vision treats operating rooms as data-producing environments whose video, audio, and device telemetry can generate real-world surgical evidence for medtech and pharma partners. Vendor-neutral aggregation matters because hospitals cannot standardize on one surgical equipment manufacturer.

For healthcare AI readers, Caresyntax is surgical workflow AI — distinct from radiology AI or ambient documentation — but shares enterprise hospital integration complexity.

Sources and references

Primary sourcing: Caresyntax newsroom CEO transition and funding releases, reviewed July 10, 2026.

  • Caresyntax — Matt Krueger CEO (caresyntax.com, July 16, 2025)
  • Caresyntax — $180M funding (caresyntax.com, August 15, 2024)

Co-founder status from official Caresyntax newsroom only.

Caresyntax’s 2024 newsroom reported joining the EU AI Pact to advance ethical AI in healthcare and winning the German AI Prize presented by Germany’s Federal Minister for Digitalization — governance milestones Kogan’s co-founding vision enabled as surgical AI scaled across European and U.S. operating rooms.

May 2025 Caresyntax partnerships with Incision, Jacobs Institute, Pristine Surgical, and Qaelon Medical per newsroom timeline show Kogan’s platform expanding real-world evidence generation across transplant, surgical training, and complication management workflows beyond core OR video analytics.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

The AI Brief

Founder and company intelligence, weekly.

Subscribe